Effect of Heparin on Tissue Binding Activity of Fibroblast Growth Factor and Heparin-Binding Epidermal Growth Factor in Experimental Colitis in Rats
- 1 May 2002
- journal article
- research article
- Published by Springer Nature in Pediatric Research
- Vol. 51 (5) , 635-640
- https://doi.org/10.1203/00006450-200205000-00015
Abstract
Pediatric Research publishes original papers, invited reviews, and commentaries on the etiologies of diseases of children and disorders of development, extending from molecular biology to epidemiology. Use of model organisms and in vitro techniques relevant to developmental biology and medicine are acceptable, as are translational human studies.Keywords
This publication has 29 references indexed in Scilit:
- Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitisGastroenterology, 2000
- Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 2000
- Unfractioned Heparin in The Therapy of Patients With Highly Active Inflammatory Bowel DiseaseAmerican Journal of Gastroenterology, 1999
- CHARACTERIZATION OF HUMAN RECOMBINANT INTERLEUKIN 2 BINDING TO HEPARIN AND HEPARAN SULFATE USING AN ELISA APPROACHCytokine, 1997
- Treatment of corticosteroid‐resistant ulcerative colitis with heparin —a report of 16 casesAlimentary Pharmacology & Therapeutics, 1997
- Heparin disaccharides inhibit tumor necrosis factor-alpha production by macrophages and arrest immune inflammation in rodents.International Immunology, 1997
- Examination of the mechanism by which heparin antagonizes activation of a model endothelium by interferon-gamma (IFN-γ)Clinical and Experimental Immunology, 1997
- 'Sticky' neutrophils, pathergic arthritis, and response to heparin in pyoderma gangrenosum complicating ulcerative colitis.Gut, 1995
- Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptorCell, 1991
- Response to heparin in patients with ulcerative colitisThe Lancet, 1991